Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Stem cell transplantation Hodgkin

Assess the role of autologous hematopoietic stem cell transplantation in relapsed Hodgkin s lymphoma and non-Hodgkin s lymphoma. [Pg.1371]

Shimoni A, Zwas ST, Oksman Y, Hardan I, et al. 2007. Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin s lymphoma. Exp Hematol. 35 534-540. [Pg.126]

V. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin s disease a randomized trial. Lancet 2002 359 2065 - 2071... [Pg.822]

Many patients with Hodgkin s lymphoma will be refractory to initial therapy or will have a recurrence following a complete remission. Response to salvage therapy depends on the extent and site of recurrence, previous therapy, and duration of initial remission. High-dose chemotherapy and autologous hematopoietic stem cell transplantation should be considered in patients with refractory or relapsed disease. [Pg.2439]

Shipp MA, Abeloff MD, Antman KH, et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin s lymphomas report of the jury. J Clin Oncol 1999 17 423-429. [Pg.2465]

Haln T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin s lymphoma an evidence-based review. Biol Blood Marrow Transplant 2001 7 308-331. [Pg.2465]

Gopal AK, Gooley TA, Maloney DG, et al. High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin s lymphoma a multivariate cohort analysis. Blood 2003 102 2351-2357. [Pg.2556]

Nademanee A et al. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. Blood 2005 106 2896-2902. [Pg.359]

In non-Hodgkin s lymphoma (NHL), post-stem cell transplant IL-2 has shown activity. Low-dose IL-2 was also evaluated in comhination with histamine, but no differences in response were observed compared with IL-2 alone. [Pg.139]

Fig. 27.8. Neutropenic febrile patient who underwent autologous stem-cell transplantation due to non-Hodgkin lymphoma. At day 2 after transplantation, neutropenia and fever occurred. Therefore, antifungal treatment (Amphotericin B) was started. Ill-defined pulmonary nodules were diagnosed at day 7. Haematological reconstitution took place at day 13, si-... Fig. 27.8. Neutropenic febrile patient who underwent autologous stem-cell transplantation due to non-Hodgkin lymphoma. At day 2 after transplantation, neutropenia and fever occurred. Therefore, antifungal treatment (Amphotericin B) was started. Ill-defined pulmonary nodules were diagnosed at day 7. Haematological reconstitution took place at day 13, si-...
Autologous hematopoietic stem cell (HSC) transplantation, a standard treatment for hematological malignancies, such as non-Hodgkin s... [Pg.515]

See other pages where Stem cell transplantation Hodgkin is mentioned: [Pg.1371]    [Pg.249]    [Pg.723]    [Pg.471]    [Pg.2444]    [Pg.277]    [Pg.745]    [Pg.573]    [Pg.469]    [Pg.516]    [Pg.56]    [Pg.340]   
See also in sourсe #XX -- [ Pg.706 ]

See also in sourсe #XX -- [ Pg.706 ]



SEARCH



Cell transplantation

Hodgkin

© 2024 chempedia.info